SPI Pharma Featured in PMPS February Edition!

05 Feb 2021

"Patient-centric, or patient friendly dosage forms like orally disintegrating tablets (ODTs), are very effective products to administer to patients who may have difficulty swallowing. These types of products actually provide more dose accuracy assurance than other dosage forms, such as oral solutions and suspensions, which can also be administered to patients with swallowability challenges. Orally dispersible dosage forms like ODTs and chewable tablets mitigate dose accuracy issues and can provide a safe and efficacious dosage form for patients who have difficulty swallowing."

Pharmaceutical Manufacturing and Packing Sourcer spoke with Doug Hovey, Technical Development Manager at SPI Pharma for North America, about the importance of formulating patient centric medicine. Read the full interview in Oral Dosage Forms and Tailoring Products to the Consumer below.

Full article

 

This article is taken from Pharmaceutical Manufacturing and Packing Sourcer February 2021, pages 36-37. © Samedan Ltd